期刊文献+

肺转移瘤^(18)F-FDG PET/CT显像分析 被引量:2

Analysis of ^(18)F-FDG PET/CT imaging of pulmonary metastasis tumors
下载PDF
导出
摘要 目的分析肺转移瘤的18F-FDG PET/CT显像结果,以期提高诊断正确率,减少漏诊和误诊。方法对68例肿瘤患者肺转移灶的18F-FDGPET/CT显像结果进行回顾性分析。结果68例CT显示阳性病例中,PET显示阳性18例,部分阳性27例,总阳性率为66.18%;阴性23例,占33.82%。CT发现病灶数目575个,PET显示194个,PET检出率为33.74%。FDG有无摄取以及摄取的程度与转移灶大小有明显关系,与原发肿瘤的来源无关。随着病灶增大,PET阳性率和SUV值均明显增高。结论18F-FDGPET对肺转移瘤、尤其是单个转移灶的鉴别诊断价值有限。 Objective To analyze ^18F-FDG PET/CT imaging of pulmonary metastasis tumors.Methods A total of 68 patients with various malignant tumors were clinically diagnosed,and images of ^18F-FDG PET/CT were analyzed retrospectively.Results CT showed pulmonary metastasis tumors in all 68 patients,while PET scan revealed positive lesions in 18,partial positive in 27,and negative in 23 patients,resulting the positive ratio of 66.18%.CT detected 575 lesions,while PET scan detected 194 lesions with detection ratio of 33.74%.FDG uptake and SUV value were obviously related to the size of metastasis lesion,but not with the primary tumor.With the enlargement of lesions,both PET positive ratio and SUV value significantly increased.Conclusion Diagnostic value of ^18F-FDG PET for pulmonary metastasis tumors,especially for single metastasis should not be over emphasized.
作者 党亚萍 王琦
出处 《中国医学影像技术》 CSCD 北大核心 2009年第9期1693-1696,共4页 Chinese Journal of Medical Imaging Technology
关键词 肿瘤转移 ~18F-氟代脱氧葡萄糖 正电子发射断层扫描 Lung Neoplasm metastasis Fluorodeoxyglucose F18 Positron-emission tomography
  • 相关文献

参考文献9

二级参考文献30

  • 1徐本华,赵献光,钱明,于金明.PET在肺癌诊断及治疗中的应用[J].国外医学(肿瘤学分册),2004,31(8):615-618. 被引量:6
  • 2周清华,孙燕.加强我国肺癌分子靶向治疗基础和临床研究[J].中国肺癌杂志,2004,7(4):267-269. 被引量:51
  • 3Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.JAMA, 2003, 290: 3199-3206.
  • 4Blomqvist L, Torkzad MR. Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology? JAMA, 2003,290: 3248-3249.
  • 5Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med, 2003, 44: 1200-1209.
  • 6Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med, 2004, 45: 82S-95S.
  • 7Goerres GW, von Schulthess GK, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med, 2004,45: 66S-71S.
  • 80llenberger GP, Weder W, yon Schulthess GK, et al. Staging of lung cancer with integrated PET/CT. N Engl J Med, 2004, 350: 86-87.
  • 9Metser U, Lerman H, Blank A, et al. Malignant involvement of the spine: assessment by 18F-FDG PET/CT. J Nucl Med, 2004, 45:279-284.
  • 10Schoder H, Yeung HWD, Gonen M, et al. Head and neck cancer:clinical usefulness and accuracy of PET/CT image fusion. Radiology,2004, 231: 65-72.

共引文献58

同被引文献32

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部